References
Y. Liel., M. Abu. Tailakh., Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting. Endocrine 63, 651–656 (2019)
A.A. Al. Nofal., O. Altayar., K. BenKhadra., O.Q. Qasim. Agha., N. Asi., M. Nabhan. et al. Bone turnover markers in Paget’s disease of the bone: a systematic review and meta-analysis. Osteoporos. Int. 26, 1875–1891 (2015)
D. Wolverton, D.P. Elliott, Evaluating the evidence behind treating osteoporosis in the oldest adults. Consult. Pharm. 33, 308–316 (2018)
Funding
This work was supported by grants from the National Natural Science Foundation of China [grant numbers 81471091 and 81870622] and the Hunan Natural Science Foundation [grant number 2018JJ2574].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All research procedures in this study were in accordance with the ethical standards of institutions and to the 1964 Helsinki declaration and its subsequent amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fu, S., Ou, Yn. & Sheng, Zf. Long-term control of Paget’s disease of bone with low-dose, once-weekly, oral bisphosphonate preparations, in a “real world” setting. Endocrine 65, 223–224 (2019). https://doi.org/10.1007/s12020-019-01966-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-019-01966-1